SCHEMBL5828616

SCHEMBL5828616

CN(C)CCCN([C]=O)CCCN(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.45
TSHR P16473 1/20 0.45
DNM1 Q05193 3/20 0.38
TDP1 Q9NUW8 2/20 0.36
PAOX Q6QHF9 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
PRMT3 O60678 1/20 0.33
CARM1 Q86X55 1/20 0.33
PRMT6 Q96LA8 1/20 0.33
PRMT1 Q99873 1/20 0.33
PRMT8 Q9NR22 1/20 0.33
KDM4A O75164 5/20 0.32
KDM4C Q9H3R0 5/20 0.32
KDM5A P29375 1/20 0.32
KDM7A Q6ZMT4 1/20 0.32
PHF8 Q9UPP1 1/20 0.32
KDM2A Q9Y2K7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5621455 0.87 ALDH1A1 (0.39) ALDH1A1TSHRDNM1CYP1A2CYP2D6
SCHEMBL6983226 0.82 CA12 (0.42) ALDH1A1TSHRTDP1CYP2C9CYP2C19
SCHEMBL1307414 0.78 ALDH1A1 (0.45) ALDH1A1TSHRDNM1TDP1CYP1A2
SCHEMBL1290871 0.74 ALDH1A1 (0.75) ALDH1A1TSHRDNM1TDP1CYP2C9
SCHEMBL212626 0.74
SCHEMBL26771 0.74 CA12 (0.37) ALDH1A1TSHRDNM1TDP1KDM4C
SCHEMBL97180 0.72 DNM1 (0.43) ALDH1A1TSHRDNM1KDM4CKDM5A
SCHEMBL10790523 0.71 ALDH1A1 (0.83) ALDH1A1TSHRDNM1TDP1CYP2C9
Bromide SCHEMBL30558707 0.71 ALDH1A1 (0.69) ALDH1A1TSHRDNM1TDP1CYP2C9
SCHEMBL26135085 0.71 ALDH1A1 (0.69) ALDH1A1TSHRDNM1TDP1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7001904-B1 Guanidine derivatives quinazoline and quinoline for use in the treatment of autoimmune diseases ASTRAZENECA AB (SE) 2006-02-21 US disclosed
EP-1296973-A1 GUANIDINE DERIVATIVES OF QUINAZOLINE AND QUINOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES AstraZeneca AB (SE) 2003-04-02 EP disclosed
WO-2002000644-A1 GUANIDINE DERIVATIVES OF QUINAZOLINE AND QUINOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES ASTRAZENECA AB (SE) 2002-01-03 WO disclosed